Antisense verses gene replacement therapy for USH1C

Authors

Jennifer J. Lentz, LSU Health Sciences Center - New OrleansFollow
Bhagwat V. Alapure, LSU Health Sciences Center - New OrleansFollow
Dongjoon Kim, LSU Health Sciences Center - New OrleansFollow
Sanford L. Boye, University of Florida, Gainesville, FL
Shannon Elizabeth Boye, University of Florida, Gainesville, FL
Wadih Zein, National Eye Institute, Bethesda, MD
Michel Michaelides, Moorfields Eye Hospital NHS Foundation Trust, London, England
Maria Reinoso, LSU Health Sciences Center - New OrleansFollow
Robert K. Koenekoop, McGill University, Montreal, Quebec, Canada

Document Type

Conference Proceeding

Publication Date

6-1-2025

Publication Title

Investigative Ophthalmology and Visual Science

Abstract

Association for Research in Vision and Ophthalmology Annual Meeting, ARVO 2025, May 4-8, 2025, Salt Lake City, UT

First Page

5945

Volume

66

Issue

8

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.

Recommended Citation

Lentz, Jennifer J.; Alapure, Bhagwat V.; Kim, Dongjoon; Boye, Sanford L.; Boye, Shannon Elizabeth; Zein, Wadih; Michaelides, Michel; Reinoso, Maria; and Koenekoop, Robert K., "Antisense verses gene replacement therapy for USH1C" (2025). School of Graduate Studies Faculty Publications. 421.
https://digitalscholar.lsuhsc.edu/sogs_facpubs/421